Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5811/westjem.2020.3.47328 http://scihub22266oqcxt.onion/10.5811/westjem.2020.3.47328 32302280!7234712!32302280     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       West+J+Emerg+Med 2020 ; 21 (3): 510-513 Nephropedia Template TP {{tp|p=32302280|t=2020. Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department |pdf=|usr=}}{{32302280}} gab.com Text Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department JO: West J Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=32302280 #FOAvip As of March 30(th), 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise. Other than supportive care, there are no SARS-CoV-2 specific treatments available for patients discharged from the emergency department (ED) or those admitted to the hospital. In addition, there are no vaccines available to protect our at-risk healthcare workers. The National Institutes of Health is conducting a Phase 1 clinical trial to evaluate for a potential vaccine and the recipients have started to receive the investigational vaccine.2 We present a brief overview of the potential prophylactic and treatment agents under investigation, some which could be initiated in the ED if proven effective. Twit Text FOAVip Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department ????West J Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=32302280 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32302280 #FOAvip English Wikipedia <ref>{{Cite pmid|32302280}}</ref> Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department #MMPMID32302280 Brown C; Noble J; Coralic Z West J Emerg Med 2020[Mar]; 21 (3): 510-513 PMID32302280show ga As of March 30(th), 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise. Other than supportive care, there are no SARS-CoV-2 specific treatments available for patients discharged from the emergency department (ED) or those admitted to the hospital. In addition, there are no vaccines available to protect our at-risk healthcare workers. The National Institutes of Health is conducting a Phase 1 clinical trial to evaluate for a potential vaccine and the recipients have started to receive the investigational vaccine.2 We present a brief overview of the potential prophylactic and treatment agents under investigation, some which could be initiated in the ED if proven effective. |*Coronavirus[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Serotherapy[MESH] |Coronavirus Infections/drug therapy/epidemiology/*therapy[MESH] |Emergency Service, Hospital[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Pandemics[MESH] |Pneumonia, Viral/epidemiology/*therapy[MESH] |Pre-Exposure Prophylaxis[MESH] |SARS-CoV-2[MESH]Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs(epmc).pdf DeepDyve Pubget Overpricing